| EFA | Epilepsy Foundation of America; essential fatty acid; extrafamily adoptee |
|---|---|
| EFAD | essential fatty acid deficiency |
| EH | enlarged heart; external hyperalimentation; epidermolytic hyperkeratosis; epoxide hydratase; essenti... |
| EHC | enterohepatic circulation; enterohepatic clearance; essential hypercholesterolemia; ethylhydrocuprei... |
| EHL | effective half-life; electrohydraulic lipotripsy; endogenous hyperlipidemia; Environmental Health La... |
para-amino salicylic acid
| essential gene | <genetics> Any gene that, if it does not workcorrectly, kills the organism. (09 Oct 1997) |
|---|---|
| essential hypertension | Hypertension without known cause. Synonym: idiopathic hypertension, primary hypertension. (05 Mar 2000) |
| essential oils | Plant products, usually somewhat volatile, giving the odours and tastes characteristic of the particular plant, thus possessing the essence, e.g., citral, pinene, camphor, menthane, terpenes; usually, the steam distillates of plants or oils of plants obtained by pressing out the rinds of a particular plant. See: volatile oil. (05 Mar 2000) |
| essential phthisis bulbi | A softening of the eyeball (ophthalmomalacia) and reduction in size, not due to inflammation. (05 Mar 2000) |
| essential progressive atrophy of iris | Progressive atrophy of the iris without inflammatory signs, characterised by patchy loss of all layers of the iris with hole formation, migration of the pupil, degeneration of the corneal endothelium, peripheral anterior synechiae, and secondary glaucoma; usually unilateral, predominantly affecting women in their middle years. (05 Mar 2000) |
| essential pruritus | Itching that occurs independently of skin lesions. (05 Mar 2000) |
| essential tachycardia | Persistent rapid action of the heart due to no discoverable organic lesion. (05 Mar 2000) |
| essential telangiectasia | Localised capillary dilation of undetermined origin. Synonym: angioma serpiginosum. (05 Mar 2000) |
| essential thrombocythaemia | A rare condition related to polycythaemia rubra vera characterised by the production of large numbers of abnormal platelets. Symptoms include haemorrhage, blood clots and enlargement of the spleen. Treatment varies according to the severity of the disease. (13 Nov 1997) |
| essential thrombocytopenia | A primary form of thrombocytopenia, in contrast to secondary forms that are associated with metastatic neoplasms, tuberculosis, and leukaemia involving the bone marrow, or with direct suppression of bone marrow by the use of chemical agents, or with other conditions. (05 Mar 2000) |
| essential tremor | <neurology> A tremor that is associated with purposeful movement or motor activity. Essential tremor is the most common form of tremor with no identifiable cause. Stress, anxiety and the use of stimulants (for example caffeine, decongestants) can often make the tremor worse. Treatment is usually not necessary for this benign condition. (27 Sep 1997) |
| fatty acids, essential | Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids. (12 Dec 1998) |
| acidic amino acid | An Amino acid with a second acid moiety, e.g., glutamic acid, aspartic acid, cysteic acid. (05 Mar 2000) |
| activated amino acid | The product formed by the condensation of the acyl radical of an amino acid and adenosine 5'-monophosphate (originally in the form of adenosine 5'-triphosphate, with elimination of a pyrophosphoric group). Formed in the first step of protein biosynthesis. Synonym: activated amino acid. (05 Mar 2000) |
| alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | <chemical> Alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid. An ibotenic acid homolog and glutamate agonist. The compound is the defining agonist for the ampa subtype of glutamate receptors (receptors, ampa). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. Pharmacological action: excitatory amino acid agonists. Chemical name: 4-Isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo- (12 Dec 1998) |